TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,614 | +26.9% | 174 | +50.0% | 0.00% | – |
| Q2 2023 | $2,847 | -40.6% | 116 | -1.7% | 0.00% | – |
| Q1 2023 | $4,792 | -81.2% | 118 | -79.2% | 0.00% | -100.0% |
| Q4 2022 | $25,442 | -15.2% | 566 | -8.7% | 0.00% | 0.0% |
| Q3 2022 | $30,000 | +66.7% | 620 | +106.0% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | +157.1% | 301 | +410.2% | 0.00% | – |
| Q1 2022 | $7,000 | +250.0% | 59 | +321.4% | 0.00% | – |
| Q4 2021 | $2,000 | – | 14 | +1300.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |